Dr. Lagarde is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23 Sunnybrook Rd
Raleigh, NC 27610Phone+1 919-350-7584Fax+1 919-231-0314
Education & Training
- University of North Carolina HospitalsFellowship, Pediatric Endocrinology, 2001 - 2004
- University of North Carolina HospitalsResidency, Pediatrics, 1998 - 2001
- Tulane University School of MedicineClass of 1998
Certifications & Licensure
- NC State Medical License 1998 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Association of social vulnerability index and masking adherence among children enrolled in COVID-19 community research partnership study.Keerti L Dantuluri, Asare Buahin, Diane Uschner, Michael E DeWitt, Whitney Rossman
BMC Public Health. 2024-02-08 - 3 citationsBreakthrough SARS-CoV-2 Infections after Vaccination in North Carolina.Diane Uschner, Matthew Bott, William H Lagarde, Joseph Keating, Hazel Tapp
Vaccines. 2022-11-13 - 7 citationsHuman plasma-derived alpha1 -proteinase inhibitor in patients with new-onset type 1 diabetes mellitus: a randomized, placebo-controlled proof-of-concept study.William H. Lagarde, Kecia L. Courtney, Barry Reiner, Kimberly Steinmann, Eva Tsalikian
Pediatric Diabetes. 2021-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: